| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |